🇺🇸 FDA
Company

Esperion

Esperion Therapeutics

ESPR pharma USA

Quick answer

Esperion is a pharma company (ESPR) headquartered in ANN ARBOR, MI, USA with 14 tracked pipeline programs.

Pipeline (14)

project

Bempedoic Acid + Ezetimibe Fixed-Dose Combination

Hyperlipidemias

Phase 3 · other · completed

1 trials project

Bempedoic acid 180 mg tablet

Cardiovascular Diseases

Phase 3 · small_molecule · completed

1 trials project

ETC-1002

Hypercholesterolemia

Phase 3 · small_molecule · completed

6 trials project

bempedoic acid

Hypercholesterolemia

Phase 3 · small_molecule · completed

5 trials project

Bempedoic acid + Ezetimibe FDC Oral Tablet

Diabetes

Phase 2 · small_molecule · completed

1 trials project

Bempedoic acid 180mg

Hypercholesterolemia

Phase 2 · small_molecule · completed

2 trials project

ETC-1002

Dyslipidemia

Phase 2 · small_molecule · completed

1 trials project

ETC-1002

Hyperlipidemia

Phase 2 · small_molecule · completed

2 trials project

ETC-1002

Safety Evaluation of Escalating Doses

Phase 1 · small_molecule · completed

1 trials project

ETC-1002 or placebo

Mild Dyslipidemia

Phase 1 · small_molecule · completed

1 trials project

[14C-ETC-1002]

Hyperlipidemia

Phase 1 · small_molecule · completed

1 trials project

Bempedoic Acid / Ezetimibe Oral Tablet

Cardiovascular Diseases

Approved · small_molecule · active

1 trials project

Bempedoic Acid 180 MG Oral Tablet

Healthy Lactating Women

Approved · small_molecule · completed

1 trials project

Cardiopulmonary Exercise Testing

Intrauterine Growth Restriction

Unknown · other · active

1 trials

Drugs (1)

drug

bempedoic acid

NEXLIZET

Patents (8)

patent

US 12404227

Methods of making bempedoic acid and compositions of the same

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12398087

Methods of making bempedoic acid and compositions of the same

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12344578

Salt forms of bempedoic acid and methods for using the same

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11987548

Methods of making bempedoic acid and compositions of the same

Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11926584

Methods of making bempedoic acid and compositions of the same

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11760714

Methods of making bempedoic acid and compositions of the same

Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11744816

Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me

Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11613511

Methods of making bempedoic acid and compositions of the same

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)